WallStreetZenWallStreetZen

NASDAQ: ASBP
Aspire Biopharma Holdings Inc Stock Ownership - Who owns Aspire Biopharma Holdings?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Aspire Biopharma Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Donald G. FellDirector2025-06-0510,500$0.39
$4.10kBuy
Donald G. FellDirector2025-06-0510,500$0.39
$4.10kBuy
Donald G. FellDirector2025-06-0510,500$0.39
$4.10kBuy
Donald G. FellDirector2025-06-049,500$0.39
$3.71kBuy
Donald G. FellDirector2025-06-049,500$0.39
$3.71kBuy
Donald G. FellDirector2025-06-049,500$0.39
$3.71kBuy

1 of 1

ASBP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ASBP insiders and whales buy or sell their stock.

ASBP Shareholders

What type of owners hold Aspire Biopharma Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Surendra K. Ajjarapu8.72%4,317,500$1.83MInsider
Powerup Sponsor LLC5.79%2,870,000$1.22MInsider
Procyon Advisors LLC1.31%648,411$275.57kInstitution
Crewe Advisors LLC1.27%626,854$266.41kInstitution
Optivise Advisory Services LLC0.47%235,106$99.92kInstitution
Jane Street Group LLC0.31%152,552$64.83kInstitution
Vr Advisory Services Ltd0.20%97,391$41.39kInstitution
Periscope Capital Inc0.15%75,000$31.88kInstitution
Three Seasons Wealth LLC0.15%75,000$31.88kInstitution
Valley Wealth Managers Inc0.08%40,000$17.00kInstitution

1 of 2

ASBP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ASBP4.13%14.55%Net Buying
CLSD25.51%74.49%Net Buying
TAOX1.77%4.51%Net SellingNet Selling
CING3.75%96.25%
CRIS6.98%93.02%
View Top Biotech Stocks

Aspire Biopharma Holdings Stock Ownership FAQ

Who owns Aspire Biopharma Holdings?

Aspire Biopharma Holdings (NASDAQ: ASBP) is owned by 4.13% institutional shareholders, 14.55% Aspire Biopharma Holdings insiders, and 81.32% retail investors. Surendra K. Ajjarapu is the largest individual Aspire Biopharma Holdings shareholder, owning 4.32M shares representing 8.72% of the company. Surendra K. Ajjarapu's Aspire Biopharma Holdings shares are currently valued at $1.78M.

If you're new to stock investing, here's how to buy Aspire Biopharma Holdings stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.